Obesity-Related Exosome Analysis Service
InquiryThe global escalation of metabolic disorders has pivoted scientific focus toward the intricate communication networks of adipose tissue. At the heart of this network are exosomes—nanosized extracellular vesicles (30–150 nm) that transport bioactive lipids, proteins, and non-coding RNAs between cells. In the context of obesity, these vesicles act as "metabolic messengers," orchestrating systemic inflammation, insulin resistance, and ectopic lipid deposition.
Obesity-Related Exosome Analysis Service
Protheragen offers a specialized obesity-related exosome analysis service designed to decode these complex signals. By leveraging high-resolution isolation and multi-omic profiling, we enable preclinical researchers to identify novel biomarkers and therapeutic targets within the adipose microenvironment. Our platform bridges the gap between basic vesicle biology and metabolic disease modeling, providing the precision required to advance next-generation obesity interventions.
Core Technologies
Protheragen employs an integrated suite of advanced analytical platforms to ensure the highest standards of exosomal integrity and data depth:
- Asymmetric Flow Field-Flow Fractionation (AF4)
A gentler, matrix-free separation technique that isolates exosome subpopulations based on hydrodynamic radius without the mechanical stress of ultracentrifugation.
- Nanoparticle Tracking Analysis (NTA)
Utilizing laser scattering and Brownian motion to provide real-time visualization, size distribution, and absolute concentration measurements of obesity-derived vesicles.
- Cryo-Electron Microscopy (Cryo-EM)
Delivering high-resolution structural validation to confirm the morphology and lipid bilayer integrity of isolated exosomes.
- High-Sensitivity Flow Cytometry (HSFC)
Enables the detection of specific surface markers (e.g., CD9, CD63, CD81) and adipose-specific cargo at the single-vesicle level.
- Mass Spectrometry-Based Omics
Specialized pipelines for exosomal lipidomics and proteomics to map the metabolic "fingerprint" of obese phenotypes.
Service Scope
Protheragen provides a modular service portfolio tailored to the unique requirements of obesity research:
Optimized protocols for extracting vesicles from challenging "lipid-rich" samples, ensuring high yields from white, brown, and beige adipose tissues.
Advanced removal of interfering metabolic byproducts and non-vesicular proteins to ensure "clean" data for downstream mass spectrometry.
Quantitative and qualitative assessment using NTA, TEM, and western blotting to verify the identity and purity of your obesity-derived samples.
In vitro and in vivo assays to evaluate how exosomes influence insulin signaling, adipogenesis, and macrophage polarization.
Modifications of exosomal surfaces or cargo loading for the development of targeted delivery systems in metabolic disease models.
Connect with Our Scientists to Optimize Your Extraction Protocol.
Workflow
Our streamlined preclinical workflow ensures reproducible results and rapid turnaround times for complex metabolic studies:
Fields of Application
Our specialized analytical platform empowers researchers to translate complex vesicular data into biological breakthroughs across several critical areas of metabolic investigation.
- Biomarker Discovery: Identifying circulating exosomal miRNAs linked to early-stage insulin resistance.
- Cross-Talk Modeling: Studying how adipocyte-derived exosomes communicate with skeletal muscle or the liver to induce systemic metabolic shifts.
- Therapeutic Delivery: Utilizing engineered exosomes as biocompatible vehicles for gene-silencing or drug delivery in obesity models.
- Inflammation Studies: Mapping the role of exosomes in mediating "inflammaging" and macrophage infiltration in visceral fat.
Advantages
Partnering with Protheragen provides your research program with unmatched technical depth:
Adipose-Specific Expertise
Unlike generic providers, we understand the specific challenges of isolating vesicles from high-lipid environments. Adipose tissue presents unique biophysical hurdles, specifically the risk of lipid droplet interference and high concentrations of free fatty acids.
Superior Purity Profiles
Our multi-modal purification strategy reduces lipoprotein contamination by up to 95%, a critical metric given that LDL and VLDL particles often co-isolate with EVs due to similar buoyant densities.
Advanced Bioinformatics
We do not just deliver raw sequencing files; we provide customized pathway analysis tailored to the metabolic landscape. Data is interpreted through the lens of inter-organ crosstalk and systemic endocrine signaling.
Preclinical Specialization
Every protocol is validated for use in murine, porcine, and in vitro obesity models, ensuring your data is ready for high-impact publication. Our isolation yields are optimized for low-volume clinical or animal biopsies, ensuring you get sufficient material for in vivo tracking or therapeutic delivery studies.
Customer Review
Precision Analytics for Breakthrough Adipose Signaling Research
"Protheragen significantly accelerated our study on the role of exosomal miR-155 in obesity-induced inflammation. Their ability to isolate high-purity vesicles from lipid-heavy samples was a game-changer for our proteomics. We plan to utilize their engineering platform for our next phase of targeted delivery studies."
Dr. S. J., Metabolic Health Institute
Unrivaled Technical Support and Structural Validation Excellence
"The depth of the characterization report provided by Protheragen was impressive. Having cryo-EM and NTA data in one package allowed us to proceed to functional assays with absolute confidence in our vesicle population. Their technical support team is exceptionally knowledgeable about adipose biology."
Dr. L. S., Preclinical Drug Development Group
Frequently Asked Questions
-
How do you handle the high lipid content in obesity-related samples?
We utilize a proprietary pre-treatment step that removes excess chylomicrons and VLDLs, which often interfere with standard exosome isolation.
-
Can you isolate exosomes from small volumes of murine serum?
Yes, our micro-scale SEC columns are optimized for volumes as low as 100 µL while maintaining high recovery rates.
-
Does Protheragen provide clinical diagnostic services?
No, all our services are strictly for preclinical research and development purposes only.
-
What is the typical turnaround time for a full lipidomic profile?
Generally, 3 to 5 weeks, depending on the sample complexity and depth of analysis required.
-
How do you ensure the exosomes remain bioactive for functional assays?
We prioritize non-chemical precipitation methods (like SEC and AF4) to maintain the native state of the lipid bilayer and surface proteins.
-
Can you help with exosome loading for engineering projects?
Certainly. We offer electroporation and incubation-based loading services for siRNAs, proteins, or small molecules.
-
Do you provide raw data or a finalized report?
You receive both: the full raw data files and a comprehensive, publication-ready report with bioinformatic visualizations.
-
What markers do you use to verify adipose-derived exosomes?
In addition to pan-exosomal markers (CD9, CD81), we can screen for adiponectin, FABP4, and other adipose-associated proteins.
-
How do I get a quote for a customized study?
Simply use the inquiry prompt below to provide your project details, and a specialist will contact you within 24 hours.
Contact Us
Protheragen is committed to providing the precision and expertise required to navigate the complexities of obesity-related extracellular vesicle research. Our integrated platform ensures that your preclinical studies are supported by robust, reproducible, and high-quality data.
Contact Protheragen for More Information and to Discuss Your Project
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.